S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth

Casara, Patrick, Davidson, James, Claperon, Audrey et al. (35 more authors) (2018) S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth. Oncotarget. pp. 20075-20088. ISSN 1949-2553

Metadata

Authors/Creators:
  • Casara, Patrick
  • Davidson, James
  • Claperon, Audrey
  • Toumelin-Braizat, Gaëtane Le
  • Vogler, Meike
  • Bruno, Alain
  • Chanrion, Maïa
  • Lysiak-Auvity, Gaëlle
  • Diguarher, Thierry Le
  • Starck, Jérôme-Benoît
  • Chen, Ijen
  • Whitehead, Neil
  • Graham, Christopher
  • Matassova, Natalia
  • Dokurno, Pawel
  • Pedder, Christopher
  • Wang, Youzhen
  • Qiu, Shumei
  • Girard, Anne-Marie
  • Schneider, Emilie
  • Gravé, Fabienne
  • Studeny, Aurélie
  • Guasconi, Ghislaine
  • Rocchetti, Franscesca
  • Maïga, Sophie
  • Henlin, Jean-Michel
  • Colland, Frédéric
  • Kraus-Berthier, Laurence
  • Gouill, Steven Le
  • Dyer, Martin JS
  • Hubbard, Roderick https://orcid.org/0000-0002-8233-7461
  • Wood, Mike
  • Amiot, Martine
  • Cohen, Gerald M
  • Hickman, John A.
  • Morris, Erick
  • Murray, James
  • Geneste, Olivier
Copyright, Publisher and Additional Information: © Casara et al.
Dates:
  • Published: 13 April 2018
Institution: The University of York
Academic Units: The University of York > Faculty of Sciences (York) > Chemistry (York)
Depositing User: Pure (York)
Date Deposited: 01 May 2018 15:20
Last Modified: 15 Sep 2019 01:30
Published Version: https://doi.org/10.18632/oncotarget.24744
Status: Published
Refereed: Yes
Identification Number: https://doi.org/10.18632/oncotarget.24744

Download

Filename: 24744_345891_5_PB.pdf

Description: 24744-345891-5-PB

Licence: CC-BY 2.5

Share / Export

Statistics